These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Chronic recurring erysipelas]. Naseman T Dtsch Med Wochenschr; 1973 Apr; 98(16):846. PubMed ID: 4266620 [No Abstract] [Full Text] [Related]
23. [Effectiveness of immunocorrective therapy of recurrent erysipelas]. Frolov VM; Rychnev VE; Peresadin NA Klin Med (Mosk); 1985 Jul; 63(7):69-73. PubMed ID: 4046540 [No Abstract] [Full Text] [Related]
24. [Principles of treatment of patients with recurrent erysipelas]. Cherkasov VL; Samotolkin KN Vrach Delo; 1983 Feb; (2):113-6. PubMed ID: 6845687 [No Abstract] [Full Text] [Related]
25. [Erysipelas as the cause of lymphedema]. Kosenkov AN; Narenkov VM; Abramov IuA Khirurgiia (Mosk); 2005; (11):51-3. PubMed ID: 16352995 [TBL] [Abstract][Full Text] [Related]
26. [The importance of local factors in recurrent erysipelas]. Stöberl C Z Hautkr; 1985 May; 60(9):712, 715-8, 721-3. PubMed ID: 4013460 [TBL] [Abstract][Full Text] [Related]
27. Erysipelas--its occurrence and clinical aspects in Prague, 1993. A retrospective study. Hribalova V; Sramek J; Vojtechovska H; Svandova E; Kriz P Adv Exp Med Biol; 1997; 418():99-101. PubMed ID: 9331609 [No Abstract] [Full Text] [Related]
31. Antibiotic use in patients with erysipelas: a retrospective study. Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544 [TBL] [Abstract][Full Text] [Related]
32. [Thymalin in the treatment of patients with erysipelas]. Pateiuk VG; Budazhabon GB; Kuznik BI; Morozov VG; Sergeeva EI Klin Med (Mosk); 1987 Jul; 65(7):110-4. PubMed ID: 3312790 [No Abstract] [Full Text] [Related]
33. [Use of specific gamma-globulin in the treatment of erysipelas and the prevention of relapse]. Khlestkov AA Klin Med (Mosk); 1973 Feb; 51(2):113-7. PubMed ID: 4121734 [No Abstract] [Full Text] [Related]
34. Erysipelas of the upper extremity following locoregional therapy for breast cancer. El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307 [TBL] [Abstract][Full Text] [Related]
35. [Erysipelas in the young population of a military hospital]. Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346 [TBL] [Abstract][Full Text] [Related]
36. [Characteristics of the clinical course of erysipelas]. Suleĭmenova ZI; Turkpenbaeva GZh; Tsoĭ IG; Turkpenbaeva AZh Klin Med (Mosk); 1985 Jan; 63(1):125-8. PubMed ID: 3990177 [No Abstract] [Full Text] [Related]
37. [Clinical picture of erysipelas based on material from the Department of Dermatology of the Academy of Medicine in Cracow in 1957-1966]. Kowarz-Sokolowska H; Duszkiewicz J; Malecka A Przegl Dermatol; 1969; 56(5):619-25. PubMed ID: 5362102 [No Abstract] [Full Text] [Related]
38. [The treatment of patients with recurrent erysipelas using corticosteroid hormones]. Lopatina ZhM Vrach Delo; 1966 Apr; 4():104-7. PubMed ID: 5990514 [No Abstract] [Full Text] [Related]
39. [Use of tserigel in the combined treatment of patients with erysipelatous inflammation]. Zimnenko PA; Sen'ko VP; Mochalov NI Vestn Khir Im I I Grek; 1986 Feb; 136(2):66. PubMed ID: 3705346 [No Abstract] [Full Text] [Related]
40. [Etiology, pathogenesis and treatment of severe recurrent forms of erysipelas of the lower extremities]. Podoprigora AP; Polishchuk IuIe; Slabinskiĭ VV; Podoprigora SP; Podoprigora OV; Poddubnyĭ AV Klin Khir; 1998; (7):36-8. PubMed ID: 9989088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]